Program

08:50 - 09:00 |

Henri Bismuth (France)

09:00 - 09:30 | Conference: The history of robotic surgery predicting the future

Pier Cristoforo Giulianotti (Chicago IL - USA)

09:30 - 10:30 | Robotic technology for HPB surgeons

• What robotic-assisted technologies are necessary for the HPB procedures?
• What are the advantages of the robotic approach in HPB surgery (with a special emphasis at the laparoscopic approach)?
• What new developments in robotic surgery are necessary (listed by priority)?

Moderator: Jean-Yves Mabrut (France)

Panel Chair: David Geller (Pittsburgh, PA - USA)
Panel members: Raphael Araujo (Brazil), Luca Aldrighetti (Italy), Jiahong Dong (China), Chris Tschuor (Denmark)

10:30 - 10:50 | Break

10:50 - 11:50 | Training and expertise in robotic HPB surgery

• What are the prerequisites for the center to perform robotic HPB surgery?
• What is optimal experience (open, lap, robotic) required for surgeons embarking on robotic HPB surgery?
• What training program are optimal for surgeons embarking on robotic HPB surgery?
• What credentialing is optimal for surgeons embarking on robotic HPB surgery? What is role of 2 surgeon technique?
• Studies needed?

Moderator: Fabrizio Panaro (France)

Panel chair: Allan Tsung (Charlottesville, VA - USA)
Panel members: Juan Pekolj (Argentina), Adnan AlSeidi (USA), Yutaro Kato (Japan), Patrick Pessaux (France)

11:50 - 13:00 | Overall evaluation of robotic HPB surgery

• What are the relevant outcomes/metrics to assess the results of HPB robotic surgery?
• What is the cost-effectiveness of the robotic approach in HPB surgery? (vs. both open and laparoscopic approaches)
• What are the unique advantages (measurable or non-measurable) of robot over lap or open routes?
• Studies needed?

Moderators: Mickaël Lesurtel (France), Michele De Oliveira (Switzerland)

Panel chair: Albert Chan (Hong Kong - China)
Panel members: Johan Pratschke (Germany), Hugo Pinto Marques (Portugal), Xiaoying Wang (China), Hop Sanderson Tran-Cao (USA), Raffaele Brustia (France)

13:00 - 14:00 | Lunch break

14:00 - 15:00 | Indications and impact of robotic liver resection (including safety, feasibility, and outcomes of robotic liver procedures)

• When suitable, should robotic anatomical and non-anatomical minor resection be used instead of (a) laparoscopic or (b) open procedures, regardless of the indication and tumor location?
• When suitable, should robotic major resection (≥3 segments) be used instead of (a) laparoscopic or (b) open procedures, regardless of the indication?
• Do the current methods for assessing surgical difficulty work well with robotic procedures?
• Studies needed?

Moderator: Olivier Scatton (France) 

Panel chair: Roberto Troisi (Napoli - Italy)
Panel members: Gi-Hong Choi (Korea), Sanket Srinivasa (New Zealand), Yuman Fong (USA), Karim Halazun (USA), Alain Valverde (France)
 

15:00 - 16:00 | Indications and impact of robotic liver resection (con't): i.e. safety, feasibility and outcomes of robotic biliary surgery and living donor hepatectomy 

• When appropriate, should robotic biliary reconstructions be used instead of (a) laparoscopic or (b) open procedures, independent of the indication?
• When appropriate, should robotic living donor hepatectomy vs. (a) laparoscopic or (b) open approaches be used?
• Should malignant lesions (such as cholangiocarcinoma) requiring (a) hepatic pedicle lymphadenectomy, (b) biliary reconstruction, or (c) vascular reconstruction be treated using robotic hepatectomy?
• Studies needed?

Moderators: Tomoaki Kato (USA), Silvio Nadalin (Germany)

Panel chair: Mohamed Rela (Chennai - India)
Panel members: Dieter Broering (Saudi Arabia), Yao-Min Wu (Taiwan), Ho-Seong Han (Korea), Brian Goh (Singapore), Ashwin Rammohan (India), Henrik Petrowsky (Switzerland)
 

16:00 - 16:30 | Break

16:30 - 18:00 | Oral communications

18:30 - 19:30 | Cocktail

08:30 - 09:30 | Complex situations in robotic liver and biliary surgery

• Should robotic hepatectomy be used on a background of (a) severe fibrosis or cirrhosis or (b) cirrhosis with clinically significant portal hypertension?
• Should robotic hepatectomy be used for the treatment of large lesions (≥10cm)?
• Are there any contraindications for robotic hepatobiliary surgery related to patient age, obesity, co-morbidities, or complex previous abdominal operations? Are they the same as for laparoscopic surgery?
• Studies needed?

Moderators: Eric Vibert (France), Luca Aldrighetti

Panel chair: Fabrizio Di Benedetto (Modena - Italy)
Panel members: John Martinie (USA), Avi Soin (India), Marcel Machado (Brazil), Matthieu D’Hondt (Belgium), François Cauchy (Switzerland)

09:30 - 10:00 | Conference: From the first liver resection to robot surgery

Henri Bismuth (Paris - France)

10:00 - 10:30 | Break

10:30 - 11:30 | Technical considerations in robotic hepato-biliary surgery

• Are there situations where robotic hepatectomy should be preferred to the laparoscopic approach?
• When and why should a surgeon consider conversion to an open approach during robotic hepato-biliary surgery? Are the timing and the rationale the same as for laparoscopic approach?
• What are the technical aspects of (a) intra-operative ultrasonography, (b) robotic liver parenchyma transection and (c) intra-operative bleeding management?
• Studies needed?

Moderators: Christophe Laurent (France), Emmanuel Melloul

Panel chair: Iswanto Sucandy (Tampa, FL - USA)
Panel members: Umberto Cillo (Italy), Jason Hawksworth (USA), Go Wakabayashi (Japan), Jawad Ahmad (UK), Chetana Lim (France)
 

11:30 - 12:00 

|Conference: What I learnt from 1000 Robotic live donor hepatectomies

Dieter Broering (Saudi Arabia)

12:00 - 12:30 | Indications and results (early and late outcomes) of robotic pancreatic resection (i.e., safety, feasibility, and outcomes of robotic pancreatic procedures)

• When appropriate, should robotic distal pancreatectomy be used instead of (a) laparoscopic or (b) open distal pancreatectomy, regardless of the indication?
• When appropriate, should robotic pancreatoduodenectomy be used instead of (a) laparoscopic or (b) open pancreatoduodenectomy, regardless of the indication?
• When appropriate, should robotic enucleation vs. (a) laparoscopic or (b) open enucleation of pancreatic lesions be used, regardless of indication?
• Are there any oncological benefits to using a robotic platform (R0 rates, number of lymph nodes)?
• Studies needed?

Moderator: Sharona Ross (USA)

Panel chair: Yuichi Nagakawa (Tokyo - Japan)
Panel members: Melissa Hogg (USA), Pier-Cristoforo Giulianotti (USA), Fabrizio Panaro (France)
 

12:30 - 14:00 | Lunch break

14:00 - 14:30 |Conference (video): The future of robotic surgery

Jacques Marescaux (Strasbourg - France)

14:30 - 15:30 | Complex situations in robotic pancreatic resection (including safety, feasibility, and outcomes in complex situations)

• Should robotic pancreatoduodenectomy be used for the treatment of (a) pancreatic ductal adenocarcinoma, (b) with or without vascular resection and (c) with or without neoadjuvant therapy?
• Should robotic distal pancreatectomy be used for the treatment of (a) pancreatic ductal adenocarcinoma, (b) with or without vascular resection and (c) with or without neoadjuvant therapy (d) with or without spleen-preservation?
• Should robotic pancreatectomy be used for the treatment of (a) right- or (b) left-sided non-malignant or pre-malignant lesions with or without underlying history of pancreatitis?
• Are there any contraindications for robotic pancreatic surgery related to patient age, obesity, co-morbidities, or complex previous abdominal operations? Are they the same as for laparoscopic surgery?
• Studies needed?

Moderators: Brock Hewitt (USA), Laurent Sulpice (France)

Panel chair: Matthew Walsh (Cleveland, OH - USA)
Panel members: Olivier Strobel (Austria), Rong Liu (China), Patricio Polanco (USA), Olivier Saint-Marc (France)
 

15:30 - 16:30 | Technical considerations in robotic pancreatic resection (con’t)

• In what circumstances should a robotic pancreatectomy be chosen over a laparoscopic procedure?
• What is the impact of the use of a robotic platform on the risk and severity of pancreatic fistula?
• During robotic pancreatic surgery, when and why should a surgeon consider switching to an open approach? Are the timing and rationale the same as for laparoscopic approach
• In robotic pancreatic surgery, what are the technical aspects of (a) closing the pancreatic stump and (b) controlling intraoperative bleeding?
• Studies needed?

Moderators: Olivier Saint Marc (France), Vito De Blasi

Panel chair: David Kooby (Atlanta, GA - USA)
Panel members: Ugo Boggi (Italy), Jin-Young Jiang (Korea), Horacio Asbun (USA), Laurent Sulpice (France)
 

16:30 - 17:00 | Break

17:00 - 18:00 | Oral communications

18:30 - 19:30 | Cocktail

20:00 - 22:30 | Gala dinner

Registration needed

09:00 - 10:30 | Video presentations

Moderators: Olivier Scatton (France) and Raffaele Brustia
(France)

10:30 - 11:00 | Break

11:00 - 12:00 | Video presentations

Moderators: Olivier Scatton (France) and Raffaele Brustia
(France)

09:00 - 12:00 | Jury deliberations and
recommendations (separate room)